Jung HE, Ku KB, Kang BH, Park JH, et al. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2. Antiviral Res 2023;216:105656.
PMID: 37327877